IP Verse

Pajaro Limited opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Pajaro Limited

Patent Number:
EP3463457
Title:
Pd-1 Blockade With Nivolumab In Refractory Hodgkin'S Lymphoma
Applicant:
BRISTOL-MYERS SQUIBB COMPANY
Opposition Date:
Mar 27, 2024
Patent Number:
EP3883865
Title:
Seal For A Single Serve Capsule
Applicant:
GCS GERMAN CAPSULE SOLUTION GMBH
Opposition Date:
Aug 9, 2023
Patent Number:
EP3265122
Title:
Combination Of A Pd-1 Antagonist And Eribulin For Treating Cancer
Applicant:
EISAI R&D MANAGEMENT CO., LTD.
Opposition Date:
Feb 3, 2023
Patent Number:
EP3464373
Title:
Use Of Anti-Pd-1 Antibody In The Treatment Of Patients With Colorectal Cancer
Applicant:
BRISTOL-MYERS SQUIBB COMPANY
Opposition Date:
Jul 26, 2022
Patent Number:
EP2575564
Title:
Brewing Apparatus For Extracting A Portion Capsule
Applicant:
EUGSTER/FRISMAG AG ELEKTROHAUSHALTGERÄTE
Opposition Date:
Jun 15, 2022
Patent Number:
EP3498734
Title:
Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer
Applicant:
MERCK SHARP & DOHME CORP.
Opposition Date:
May 31, 2022
Patent Number:
EP3336013
Title:
Caspule And Method For Making A Beverage Using Such A Capsule
Applicant:
K-FEE SYSTEM GMBH
Opposition Date:
Feb 28, 2022
Patent Number:
EP3716823
Title:
Cartridge Receptacle, Cartridge System, Beverage Preparation Machine, And Method For Producing A Beverage
Applicant:
FREEZIO AG
Opposition Date:
Feb 28, 2022
Patent Number:
EP3656765
Title:
Salts Or Co-Crystals Of 3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-Phenol
Applicant:
GRÜNENTHAL GMBH
Opposition Date:
Jan 14, 2022
Patent Number:
EP3288980
Title:
Treatment Of Pd-L1-Positive Melanoma Using An Anti-Pd-1 Antibody
Applicant:
BRISTOL-MYERS SQUIBB COMPANY
Opposition Date:
Dec 9, 2021

Competitors of Pajaro Limited

MERCK SHARP & DOHME CORP.

BRISTOL-MYERS SQUIBB COMPANY

MERCK SHARP & DOHME LLC

Want to track Pajaro Limited?

Feel free to send us a message here and we will get back to you